With Trump's latest threat of a 200% tariff on generic medicines, we look at where the pharmaceutical industry stands
Senior Healthcare Economist
A prescription for power – China's biotech boom and the new global…
How technology could cut millions of hospital visits across Europe
Remote care technology is becoming a critical solution to mounting capacity pressures
ING Think has analysts all over the world who write about their dedicated region.
China: the next Pfizer will be Chinese
China’s spectacular rise reshapes Asia’s pharma future
South Korea: Asia’s second innovation engine
India: from generics giant to innovation powerhouse?
Japan: Asia's Europe?
Makary's successor faces tough task managing FDA amid budget cuts
Trump's 100% pharma tariffs will have a limited effect on the sector
